Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Structural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple Sclerosis.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
Sequencing analysis of the human glucocorticoid receptor (NR3C1) gene in multiple sclerosis patients.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
The Sphingosine 1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Post-Infarction Left Ventricular Remodeling in a Porcine Model of Ischemia-Reperfusion.
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
New Microparticle Secondary Progressive MS Therapy Dosing Tested In Australian Clinical Trial
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN)
Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
Lower motor neuron involvement in longitudinally extensive transverse myelitis with and without aquaporin-4 antibodies.
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
An update on neuro-ophthalmology of multiple sclerosis: the visual system as a model to study multiple sclerosis.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis.
Promoting physical activity to control multiple sclerosis from childhood.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.
Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.
Jekyll and Hide: The two faces of amyloid β.
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
Pages
« first
‹ previous
…
230
231
232
233
234
235
236
237
238
…
next ›
last »